SMS Pharmaceuticals has invested an amount of Rs 6.98 crore in equity shares of VKT Pharma, an associate company, by subscribing 310,000 equity shares, face value of Rs 10 each at a price of Rs 225 per share, including premium of Rs 215 per share, which have been allotted to the company. After considering this present acquisition, the total holding of the company stood at 40.26% in the total paid-up share capital of VKT Pharma.
SMS Pharmaceuticals is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: